Rexulti 2 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FA1GP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $186,055
Award facts
- Contract value 100% obligated
- $186,054.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $186,054.96 to AmerisourceBergen Drug Corp for the supply of REXULTI (brexpiprazole) 2 mg tablets in quantities of 30 units. This firm fixed-price, non-set-aside contract was executed on January 20, 2026, with an ultimate completion date of January 21, 2026. The order will be fulfilled from AmerisourceBergen's corporate offices located in Conshohocken, Pennsylvania. This delivery order represents a task order issued under AmerisourceBergen's parent company, Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, which carries a potential value of $999,999,999.00 through December 31, 2031.
REXULTI is an atypical antipsychotic medication used in treating schizophrenia and major depressive disorder, making this procurement consistent with DLA's mission to support military healthcare systems worldwide. AmerisourceBergen, as a major pharmaceutical distributor, regularly supplies brand-name and generic medications to federal medical programs serving active-duty personnel, veterans, and other government healthcare beneficiaries. The firm fixed-price structure and rapid completion timeline reflect the established vendor relationship and streamlined ordering processes typical of mature pharmaceutical supply arrangements within the federal medical procurement system.
Quick answers
Who was awarded contract SPE2DR26FA1GP?
SPE2DR26FA1GP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FA1GP worth?
The government has obligated $186,055 on SPE2DR26FA1GP.
Is contract SPE2DR26FA1GP an order under another contract?
Yes. SPE2DR26FA1GP is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FA1GP competed?
The extent of competition for SPE2DR26FA1GP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award